Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure
EF Christensen, R Dahl - Lung, 1991 - Springer
Patients with chronic bronchitis were randomly allocated to 4 weeks treatment with
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …
Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure
EF Christensen, R Dahl - Lung, 1991 - pubmed.ncbi.nlm.nih.gov
Patients with chronic bronchitis were randomly allocated to 4 weeks treatment with
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …
Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure
EF Christensen, R Dahl - Lung, 1991 - vbn.aau.dk
Patients with chronic bronchitis were randomly allocated to 4 weeks treatment with
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …
Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure.
EF Christensen, R Dahl - Lung, 1991 - europepmc.org
Patients with chronic bronchitis were randomly allocated to 4 weeks treatment with
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …
terbutaline 0.5 mg inhaled through a cone spacer with an expiratory resistance creating a …